Filed: 5/14/2026ACC: 0001193125-26-224227
📋 What this filing means
EQT FUND MANAGEMENT S.A R.L. filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $1.02B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$1.02B
Total AUM (reported)
44.28M
Total Shares
Allocation by class
COM$696.59M68.2%
ORDINARY SHARES$156.89M15.4%
COM SHS$113.33M11.1%
SPONSORED ADS$53.94M5.3%
Portfolio Concentration
Top 3$870.06M85.2%
4–10$150.68M14.8%
Top 3 weight
85.2%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 44.28M
Sole
Full voting authority
44.28M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings5
Rows:
WAYSTAR HLDG CORP
SOLEShares24.88M
TypeSH
Market value$599.84M
58.77%
Sole
24.88M
Shared
0.00
None
0.00
OCULIS HOLDING AG
SOLEShares5.90M
TypeSH
Market value$156.89M
15.37%
Sole
5.90M
Shared
0.00
None
0.00
EVOMMUNE INC
SOLEShares4.93M
TypeSH
Market value$113.33M
11.10%
Sole
4.93M
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares3.42M
TypeSH
Market value$96.75M
9.48%
Sole
3.42M
Shared
0.00
None
0.00
AGOMAB THERAPEUTICS NV
SOLEShares5.14M
TypeSH
Market value$53.94M
5.28%
Sole
5.14M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
WAYSTAR HLDG CORPSOLE | COM | 24.88M | SH | $599.84M 58.77% | 24.88M | 0.00 | 0.00 |
OCULIS HOLDING AGSOLE | ORDINARY SHARES | 5.90M | SH | $156.89M 15.37% | 5.90M | 0.00 | 0.00 |
EVOMMUNE INCSOLE | COM SHS | 4.93M | SH | $113.33M 11.10% | 4.93M | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 3.42M | SH | $96.75M 9.48% | 3.42M | 0.00 | 0.00 |
AGOMAB THERAPEUTICS NVSOLE | SPONSORED ADS | 5.14M | SH | $53.94M 5.28% | 5.14M | 0.00 | 0.00 |